PDCD1 and melanoma: Like obesity, it was found that tumour cholesterol content also influenced a PD1+CD8+ T‐cell phenotype in murine melanoma TILs dose‐dependently, thus once again potentially providing more substrate for anti‐PD1 efficacy [71].